ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
54 hedge funds and large institutions have $7.86M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
54
Holding in Top 10
–
Calls
$7K
Puts
–
Top Buyers
| 1 | +$264K | |
| 2 | +$251K | |
| 3 | +$175K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$98.9K |
| 5 |
RB
Richmond Brothers
Jackson,
Michigan
|
+$30.1K |
Top Sellers
| 1 | -$79K | |
| 2 | -$73.4K | |
| 3 | -$67K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$54.4K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$43.7K |